The global toxicology drug screening market is expected to reach $71,901.8 million by 2032, up from $23,888.5 million in 2022, at a CAGR of 10.5% during the forecast period. Toxicology drug screening is a set of diagnostic tests carried out to detect the presence of legal and illegal drugs uptake by an individual. It usually determines the type and approximate concentration of drug in the human body. Commonly, blood and urine samples are obtained from patient in order to perform toxicology drug screening. In addition, with blood and urine samples, hair and oral fluids are other sample forms used to determine presence of drug in the body.
To remain ahead of your competitors, request for a sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5110
Toxicology screening process can be done very quickly and provides approximate results showing the presence of specific drug in the system. Toxicological screening is done for four primary purposes that includes medical testing, employment drug testing, forensic analysis, and athletics testing. Toxicological drug screening enables control in consumption of illegal drugs such as alcohol, barbiturates, benzodiazepines, opiates, tricyclic antidepressants, and amphetamines.
A doctor or physician performs a toxicology screen in case of accidents or sexual assaults on a person if suspected with the drug intoxication or overdose symptoms including unconsciousness, difficulty breathing, panic attacks, chest pain, deliriousness, and seizures. However, toxicological drug screening is also performed before undergoing an organ transplant, drug abuse, during pregnancy.
Toxicology drug screening find vast applications in food and beverage industries, chemical industries, cosmetics and households and pharmaceutical companies which increases the demand in toxicology drug screening market. These screening tests are majorly intended for detection of illegal drugs in victim’s blood or urine sample. Biochemical assays, cellular assays, reagents and kits, in silico services are the major type of toxicological drug screening products available in the industry.
Many of these screening tests are performed to determine systemic toxicity, carcinogenicity, dermal toxicity, genotoxicity, neurotoxicity, and organ-specific toxicity and thus contribute majorly to the revenue generation in toxicology drug screening market. These toxicology drug screening methods are performed using various high-end technologies such as high-throughput screening, genomics, transcriptomics, and molecular screening. The increasing usage of toxicological screening generates large revenues in the toxicology drug screening market owing to their increased demand in hospitals and trauma centers, rehabilitation centers and forensic laboratories.
On the other hand, toxicology drug screening market is gaining profit due to rising cases of sexual assault and accidents across the globe. Increasing adoption of in-vitro methods to detect toxic drugs in human system tends to propel the growth of toxicology drug screening market across the globe and registers a significant revenue growth in the toxicology drug screening market.
Speak to our Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-5110
Toxicology Drug Screening: Market Dynamics
Growing technological advancements leading to development of novel screening products, increasing availability of high-end drug screening instruments, reagent and kits coupled with wide application areas for toxicology drug screening are some of the major factors expected to drive the growth of toxicology drug screening market. Introduction of rapid and automated toxicity detection technologies, increasing government expenditure on toxicity testing and favorable reimbursement policies in toxicity screening is further propelling the growth of toxicology drug screening market. Also, rise in demand for toxicology drug screening in the food and beverage industry, and chemical industry is also expected to drive the growth of toxicology drug screening market. However, inadequate efficacy of conventional techniques and longer time taken by laboratories for sample testing are some of the factors restraining the toxicology drug screening market growth.
Toxicology Drug Screening Market: Region-wise Outlook
On the basis of geography, global toxicology drug screening market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. Europe is projected to hold largest shares in the global toxicology drug screening market primarily due to growing R&D activities to detect toxicity levels in the human body at early stages. Europe is followed by North America which registers second largest shares in global toxicology drug screening market worldwide. However, Asia Pacific is expected to experience a robust growth over the forecast period and generates high revenues in global toxicology drug screening market.
Toxicology Drug Screening Market: Key Players
Some of the key players present in global toxicology drug screening market are Agilent Technologies, Inc., Covance, Inc., Bio-Rad Laboratories, Inc., General Electric Company, BioReliance, Inc., Thermo Fisher Scientific, Inc., Eurofins Scientific SE, GE Healthcare, Quest Diagnostics, Alere, Inc., Enzo Life Sciences, Inc. and others.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Purchase This Report@ https://www.futuremarketinsights.com/checkout/5110
Toxicology Drug Screening Market: Segmentation
The global Toxicology Drug Screening market is segmented by product type and end user:
Segmentation by Product Type
- Assays
- Biochemical Assays
- Cellular Assays
- Reagents & Kits
- Enzyme Linked Immuno-Sorbent Assay (ELISA)
- Polymerase Chain Reaction (PCR)
- Enzyme Multiplied Immuno Assay (EMIT)
- Radio Immuno-Sorbent Assay (RIA)
- Instruments
- Immunochemistry Analyzers
- PCR machine
- High-Performance Liquid Chromatography (HPLC)
- In-Silico Services
Segmentation by Test Type
- Acute Systemic Toxicity
- Dermal Toxicity
- Carcinogenicity
- Ocular Toxicity
- Genotoxicity
- Neurotoxicity
- Organ-Specific Toxicity
Segmentation by Technology Type
- High-Throughput Screening
- Genomics
- Transcriptomics
- Toxicogenomics
- Molecular Screening
Segmentation by End User
- Hospitals and Trauma Centers
- Forensic Laboratories
- Diagnostic Laboratories
- Rehabilitation Centers
- Pharmaceutical & Biotechnology Companies
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
